CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

The developing human brain gains billions of neurons while in the womb, and tacks on some more during childhood. For most of ...

Most of the cells in our bodies don't move—they stay where they're supposed to in service to our organs and biological ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

What if the secret to staying young wasn't another costly cream or trendy supplement, but tamping down a messy kind of cell ...

A 51-year-old `fit and healthy’ sports teacher died within ten days of being diagnosed with a killer brain tumour. According ...

A lab-designed molecule developed and extensively studied could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

Phase I trial patients experienced shrinkage of brain tumors and extended survival rates beyond the standard prognosis of one ...

With co-lead Professor Thomas Carew and colleagues, Kukushkin carried out experiments in the lab using two immortalized human ...

Her Excellency the Honourable Sam Mostyn AC, Governor-General of the Commonwealth of Australia, and Patron of Cancer Council ACT ...